We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEA icon
601
Lear
LEA
$7.19B
$15.7M 0.02%
+165,902
New +$16.5M
KIM icon
602
Kimco Realty
KIM
$17.6B
$15.7M 0.02%
670,292
+650,440
+3,276% +$15.8M
MCW
603
DELISTED
Mister Car Wash
MCW
$15.7M 0.02%
2,152,718
+1,094,751
+103% +$8M
XPRO icon
604
Expro Ltd
XPRO
$1.79B
$15.7M 0.02%
1,257,383
+135,281
+12% +$1.88M
FR icon
605
First Industrial Realty Trust
FR
$8.88B
$15.7M 0.02%
312,730
+128,692
+70% +$6.83M
EXP icon
606
Eagle Materials
EXP
$6.6B
$15.7M 0.02%
63,507
-103,678
-62% -$29.9M
SF
607
Stifel
SF
$12.3B
$15.7M 0.02%
221,375
-466,582
-68% -$33.3M
CPA icon
608
Copa Holdings
CPA
$5.56B
$15.7M 0.02%
178,127
+20,324
+13% +$1.93M
MOH icon
609
Molina Healthcare
MOH
$10.3B
$15.6M 0.02%
53,584
-18,237
-25% -$5.63M
SNAP icon
610
Snap
SNAP
$7.32B
$15.6M 0.02%
1,447,307
-10,318,408
-88% -$116M
TJX icon
611
TJX Companies
TJX
$170B
$15.5M 0.02%
128,542
-804,987
-86% -$96.1M
FRO icon
612
Frontline
FRO
$8.75B
$15.5M 0.02%
1,090,427
+630,685
+137% +$11.8M
GTY
613
Getty Realty Corp
GTY
$2.1B
$15.4M 0.02%
512,268
+225,752
+79% +$7.16M
FOUR icon
614
Shift4
FOUR
$3.84B
$15.4M 0.02%
148,626
+143,285
+2,683% +$14.2M
BTU icon
615
Peabody Energy
BTU
$2.78B
$15.4M 0.02%
+733,121
New +$18.1M
BABA icon
616
Alibaba
BABA
$269B
$15.2M 0.02%
179,726
-1,477,990
-89% -$140M
MRX
617
Marex Group Limited Ordinary Shares
MRX
$4.72B
$15.2M 0.02%
488,580
+86,694
+22% +$2.43M
NSIT icon
618
Insight Enterprises
NSIT
$3.55B
$15.2M 0.02%
+100,064
New +$17.9M
ECPG icon
619
Encore Capital Group
ECPG
$1.93B
$15.2M 0.02%
318,096
+134,309
+73% +$6.37M
MRVI icon
620
Maravai LifeSciences
MRVI
$997M
$15.1M 0.02%
2,778,497
+2,763,072
+17,913% +$17.8M
ACHC icon
621
Acadia Healthcare
ACHC
$3.17B
$15.1M 0.02%
380,391
+128,142
+51% +$5.78M
MSCI icon
622
MSCI
MSCI
$40B
$15M 0.02%
25,062
-28,454
-53% -$17.1M
BLMN icon
623
Bloomin' Brands
BLMN
$680M
$15M 0.02%
1,225,608
+1,015,372
+483% +$14.6M
HTGC icon
624
Hercules Capital
HTGC
$2.94B
$14.9M 0.02%
+740,210
New +$14.4M
CCS icon
625
Century Communities
CCS
$2B
$14.9M 0.02%
202,518
+175,887
+660% +$15.7M

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.